NCI Drug Dictionary

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

The NCI Drug Dictionary contains technical definitions and synonyms for drugs/agents used to treat patients with cancer or conditions related to cancer. Each drug entry includes links to check for clinical trials listed in NCI's List of Cancer Clinical Trials.

yttrium Y 90 ibritumomab tiuxetan
A radioimmunotherapeutic agent consisting of a murine monoclonal anti-CD20 antibody (ibritumomab) linked by the chelator tiuxetan to the radioisotope yttrium-90 (Y 90). Yttrium Y 90 ibritumomab tiuxetan binds to and specifically delivers beta radiation to CD20-expressing tumor cells, thereby minimizing the systemic effects of radiation. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
Synonyms:90Y ibritumomab tiuxetan
Ibritumomab (In2B8/Y2B8 radiolabeling kit)
ibritumomab tiuxetan
IDEC-Y2B8 monoclonal antibody
Y90 Zevalin
Y90-labeled ibritumomab tiuxetan
Yttrium-90 ibritumomab tiuxetan
US brand name:Zevalin
Code name:IDEC Y2B8